You have to be signed in to use this resource.
Talk 2 - Secondary bacterial and fungal infections: the impact of COVID-19
India is diverse in culture and heritage as well as the facilities there are for diagnosing infectious diseases. Patients in the first and second wave of the COVID-19 pandemic have been administered high doses of steroids and other immunosuppressive agents. This increases immunosuppression in the patient and the propensity to suffer from secondary infections, Dr Ranganathan N Iyer presents data from Indian centres who have experience in dealing with the diagnosis and outcome analysis of secondary bacterial and fungal infections in COVID-19 patients.
Resource details
| Contributed by: | Pathology Portal |
| Authored by: |
|
| Licence: | © All rights reserved More information on licences |
| First contributed: | 28 May 2026 |
| Audience access level: | General user |
Share this resource
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.